WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR MAY ISSUE PUBLISHED

    MAY 2020 Issue has been successfully launched on 1 May 2020.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR 1 May 2020 Issue has been Published, Kindly check it on http://www.wjahr.com/home/current_issues

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

THE PROGNOSTIC VALUE OF CD10 IN PATIENTS WITH B-ACUTE LYMPHOBLASTIC LEUKEMIA: 10-YEAR EXPERIENCE

Rim Zakaria Alkasem*, Suzanne Alshemali and Firas Hussein

ABSTRACT

Determination of prognostic factors in patients with acute leukemia is crucial in reducing intensive chemotherapy, decreasing economic costs, and improving the outcome of the patients. We conducted this study to determine the prognostic value of CD10 expression in B-acute lymphoblastic leukemia (studying the relationship between CD10 expression and therapeutic response, overall survival, and event-free survival). Also, we want to study the combined expression of CD10 and CD34, and the effect on overall survival and event-free survival. A retrospective study included 119 patients from 1st January 2010 to 31 December 2016. We monitored the patients until 1st December 2019. In B-acute lymphoblastic leukemia, expression of CD10 was 81.5%. Most patients whose Blasts had CD10+ were children and standard risk stratification. In contrast, patients with CD10- had significantly an increased incidence of B symptoms, fever (infection), and cerebrospinal fluid infiltration. We found that complete remission after 4 weeks and after 18 months of starting treatment was significantly higher in CD10+ patients than CD10- patients and in CD10+ and/or CD34+ patients than CD10-CD34- patients. Death was significantly higher in patients with CD10- than CD10+. The median survival rate was higher in patients with CD10+ than CD10- and in CD10+ and\or CD34+ patients than CD10-CD34- patients but without statistical significance. Our findings suggest that CD10 expression and the combined expression of CD10 and CD34 have a favorable prognosis in patients with B-acute lymphoblastic leukemia.

[Full Text Article]